BCAT1: A risk factor in multiple cancers based on a pan-cancer analysis.
Guo-Sheng LiHe-Qing HuangYao LiangQiu-Yu PangHao-Jia SunZhi-Guang HuangYi-Wu DangLin-Jie YangGang ChenPublished in: Cancer medicine (2022)
For the first time, the research comprehensively demonstrates the overexpression of BCAT1 in pan-cancer, which improves the understanding of the pathogenesis of BCAT1 in pan-cancer. Upregulated BCAT1 expression represented a poor prognosis for cancers patients, and it serves as a potential marker for cancer immunotherapy.